SCHEMBL15030565

SCHEMBL15030565

COc1ccc(Cl)cc1C(=O)Cn1cccc(C)c1=O

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.51
▸ KDM4E B2RXH2 1/20 0.51
▸ MMP2 P08253 1/20 0.51
▸ MMP3 P08254 1/20 0.51
▸ MMP8 P22894 1/20 0.51
▸ MMP14 P50281 1/20 0.51
▸ MMP17 Q9ULZ9 1/20 0.51
▸ KMT2A Q03164 3/20 0.49
▸ MEN1 O00255 1/20 0.49
▸ THRB P10828 1/20 0.48
▸ LMNA P02545 1/20 0.46
▸ RXFP1 Q9HBX9 1/20 0.45
▸ MAPT P10636 3/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ TSHR P16473 2/20 0.44
▸ DNMT3A Q9Y6K1 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16806639 0.90 KMT2A (0.47) ALDH1A1KDM4EMMP2MMP3MMP8
SCHEMBL15030419 0.88 KMT2A (0.58) ALDH1A1KDM4EKMT2AMEN1MAPT
SCHEMBL16806638 0.84 IDO1 (0.45) ALDH1A1KDM4EMMP2MMP3MMP8
SCHEMBL15030560 0.82 KMT2A (0.48) ALDH1A1KDM4EKMT2AMEN1MAPT
SCHEMBL15030513 0.81 RAB9A (0.58) ALDH1A1KMT2AMEN1LMNARXFP1
SCHEMBL15030562 0.80 PDE4B (0.61) ALDH1A1KDM4E
SCHEMBL15030561 0.80 SMN1; SMN2 (0.45) ALDH1A1KDM4EMMP2MMP3MMP8
SCHEMBL15030487 0.77 ALDH1A1 (0.52) ALDH1A1KDM4EKMT2AMEN1THRB
SCHEMBL15030414 0.76 PDE4B (0.49) ALDH1A1KDM4EKMT2AMEN1THRB
SCHEMBL15030415 0.73 ALDH1A1 (0.56) ALDH1A1KDM4ETHRBLMNARXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10000476-B2 Pyridone derivative, pharmaceutical containing the same and methods of use thereof KAKEN PHARMACEUTICAL CO., LTD. (JP) 2018-06-19 — — US disclosed
US-10000476-B2 Pyridone derivative, pharmaceutical containing the same and methods of use thereof KAKEN PHARMACEUTICAL CO., LTD. (JP) 2018-06-19 — — US disclosed
US-20160340349-A1 PYRIDONE DERIVATIVE AND PHARMACEUTICAL CONTAINING SAME KAKEN PHARMACEUTICAL CO., LTD. (JP) 2016-11-24 — — US disclosed
US-20160340349-A1 PYRIDONE DERIVATIVE AND PHARMACEUTICAL CONTAINING SAME KAKEN PHARMACEUTICAL CO., LTD. (JP) 2016-11-24 — — US disclosed
US-9447072-B2 Pyridone derivative and pharmaceutical containing same KAKEN PHARMACEUTICAL CO., LTD. (JP) 2016-09-20 — — US disclosed
US-9447072-B2 Pyridone derivative and pharmaceutical containing same KAKEN PHARMACEUTICAL CO., LTD. (JP) 2016-09-20 — — US disclosed
US-20160168540-A1 COMPOSITION FOR MAINTAINING PLATELET FUNCTION KAKEN PHARMACEUTICAL CO., LTD. (JP) 2016-06-16 — — US disclosed
US-20160168540-A1 COMPOSITION FOR MAINTAINING PLATELET FUNCTION KAKEN PHARMACEUTICAL CO., LTD. (JP) 2016-06-16 — — US disclosed
EP-3006029-A1 COMPOSITION FOR MAINTAINING PLATELET FUNCTION Kaken Pharmaceutical Co., Ltd. (JP) 2016-04-13 — — EP disclosed
US-20150166506-A1 PYRIDONE DERIVATIVE AND PHARMACEUTICAL CONTAINING SAME KAKEN PHARMACEUTICAL CO., LTD. (JP) 2015-06-18 — — US disclosed
US-20150166506-A1 PYRIDONE DERIVATIVE AND PHARMACEUTICAL CONTAINING SAME KAKEN PHARMACEUTICAL CO., LTD. (JP) 2015-06-18 — — US disclosed
WO-2013085016-A1 PYRIDONE DERIVATIVE AND MEDICINE CONTAINING SAME 科研製薬株式会社 (JP) 2013-06-13 — — WO disclosed
WO-2013085017-A1 PYRIDONE DERIVATIVE AND MEDICINE CONTAINING SAME 科研製薬株式会社 (JP) 2013-06-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160340349-A1 PYRIDONE DERIVATIVE AND PHARMACEUTICAL CONTAINING SAME PLPBP, PDXK, PNPO ALDH1A1 327/4885KDM4E 1409/4885MMP2 3807/4885
US-10000476-B2 Pyridone derivative, pharmaceutical containing the same and methods of use thereof PNPO, PDXK, PLPBP ALDH1A1 368/4885KDM4E 1371/4885MMP2 3288/4885
US-20160168540-A1 COMPOSITION FOR MAINTAINING PLATELET FUNCTION PF4, F2, PFKP ALDH1A1 1362/4885KDM4E 4157/4885MMP2 3378/4885
US-20150166506-A1 PYRIDONE DERIVATIVE AND PHARMACEUTICAL CONTAINING SAME PLPBP, PDXK, PNPO ALDH1A1 327/4885KDM4E 1409/4885MMP2 3807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback